Queensland researchers are a step closer to developing new medicines for treating inflammatory diseases, including allergies such as rhinitis, itchy hives, asthma, eczema and dermatitis. [ + ]

Emerson has selected Enterprise System Partners (ESP), a consulting and project engineering company, to collaborate with and assist life sciences manufacturers in implementing the Syncade manufacturing execution system (MES). [ + ]

An international group of scientists is homing in on a potential treatment for osteoporosis, after performing the largest ever genetic study of the common age-related bone-thinning disease. [ + ]

Researchers have released a theoretical approach to explain inconsistencies between crystallographic and chemical experimental data in the apparent transformation of a pyrochlore to defect fluorite in La₂Zr₂O₇. [ + ]

Global US food and animal safety company Neogen Corporation has acquired the assets of The University of Queensland Animal Genetics Laboratory (AGL). [ + ]

European women with ovarian cancer should stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to the results of the phase III ICON8 trial. [ + ]

CSIRO, Monash University and the Monash Health Translation Precinct (MHTP) have announced the creation of M2 — a new facility that combines technology, research and medical science. [ + ]

Early bird registrations for APSA 2017 have been extended to Friday, 15 September. [ + ]

Scientists working on malleable electronics, more effective blood tests and lasers were just some of the winners at the 2017 Australian Museum Eureka Prizes. [ + ]

New Zealand researchers have discovered an unexpected role for a white blood cell called the natural killer (NK) cell — a critical cell for ridding the body of infection and cancer. [ + ]

MTPConnect and CII have signed a memorandum of understanding (MoU) to work collaboratively to boost the innovative medical technology, biotechnology and pharmaceutical sectors in India and Australia. [ + ]

Researchers have developed an imaging technique that can help assess the quality of early-stage embryos. [ + ]

In Australia, around 52,000 people will be diagnosed with rare and less common (RLC) cancers in 2017, according to estimates by Cancer in Australia 2017. [ + ]

Three Australian cancer treatment centres are involved in a drug trial that could see the next major advancement in ovarian cancer therapy. [ + ]

Medical device company Avita Medical has named Erin Liberto as the company's chief commercial officer. [ + ]